Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00852241 · ClinicalTrials.gov registry record · Phase 4
Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study
A Phase 4 study of Infraorbital Hollows, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT00852241 is a Phase 4 study of Infraorbital Hollows that has completed, run by The Cleveland Clinic. The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00852241, a Phase 4 study of Infraorbital Hollows, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine the efficacy and longevity of the use of Restylane® and Perlane® in combination for the rejuvenation of the infraorbital hollows and to measure patient satisfaction with this treatment
Conditions Studied
Interventions
- DRUG Restalyne
- DRUG Perlane
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00852241
The ClinicalTrials.gov registry entry for NCT00852241 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infraorbital Hollows appearing as the primary indexed condition, and to 2 interventions - of which Restalyne is the first listed.
NCT00852241 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00852241 about?
NCT00852241 is a clinical study titled "Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study". The primary objective of this study is to determine the efficacy and longevity of the use of Restylane® and Perlane® in combination for the rejuvenation of the infraorbital hollows and to measure patient satisfaction with this treatment
What is the current status of trial NCT00852241?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2009-02. Estimated completion is 2009-09.
What conditions does trial NCT00852241 study?
This clinical trial studies the following conditions: Infraorbital Hollows.
What interventions are being tested in trial NCT00852241?
The interventions under investigation include: Restalyne (DRUG), Perlane (DRUG).
Who is sponsoring clinical trial NCT00852241?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00852241 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.